Clinical Trial Results: ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease [NA]

View source ↗

Summary

Clinical trial results for ExAblate Transcranial MRgFUS targeting the subthalamic nucleus in Parkinson's disease have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ExAblate Transcranial MRgFUS (MR-guided focused ultrasound)

Snippet

Sponsor: InSightec | Conditions: Parkinson's Disease | NA | Status: COMPLETED | Results posted: 2026-08-13